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Abstract: The need for easily biodegradable and less toxic chemicals in drug development and pest 
control continues to fuel the exploration and discovery of new natural molecules. Like certain 
plants, some insects can also respond rapidly to microbial infections by producing a plethora of 
immune-induced molecules that include antibacterial and antifungal peptides/polypeptides 
(AMPs), among other structurally diverse small molecules. The recent recognition that new natural 
product-derived scaffolds are urgently needed to tackle life-threatening pathogenic infections has 
been prompted by the health threats posed by multidrug resistance. Although many researchers 
have concentrated on the discovery of AMPs, surprisingly, edible insect-produced AMPs/small mol-
ecules have received little attention. This review will discuss the recent advances in the identifica-
tion and bioactivity analysis of insect AMPs, with a focus on small molecules associated with the 
microbiota of selected African edible insects. These molecules could be used as templates for devel-
oping next-generation drugs to combat multidrug-resistant pathogens. 




Plants are the primary sources of natural products, having contributed immensely to 
drug discovery for the treatment of a variety of human diseases. However, the arsenal of 
secondary metabolites has recently expanded to include those of microbial origin associ-
ated with insects [1]. The early regime of antibiotics was boosted by the “accidental” dis-
covery of penicillin (β-lactam), isolated from the fungus Penicillium sp., whose mode of 
action entailed targeting bacterial cell wall synthesis. Subsequent investigations in the 
field of antibiotic metabolites led to the discovery of many other classes of antimicrobial 
compounds through conventional fermentation procedures. However, the systematic 
emergence of resistance towards the available classes of antibiotics has increasingly posed 
a major challenge [2]. This has continued to justify the search for new antimicrobial me-
tabolites, with potentially new modes of action, towards countering the problem of multi-
drug resistance. 
Bacteria and fungi, like many other organisms, must compete for resources by using 
a range of strategies, including those inflicted directly by toxins and indirectly through 
the activity of host immune responses, which results in changes in pathogenicity [3]. Bac-
terial and fungal interactions with their hosts including insects are crucial for many bio-
logical processes in agriculture, waste management, food production, and medicine [4,5]. 
Reviews on the nutritional value of certain insects, such as black soldier fly larvae, 
housefly maggot and pupae, mealworms, silkworm pupae, locusts, beetles, grasshoppers, 
and crickets, show that they have the potential to be used as an alternative protein source 
in various livestock feeds [6,7]. Additionally, insect meals can be used effectively in rear-
ing of animals, such as poultry, to enhance animal health, intestinal morphology, and the 
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composition of the intestinal microbiota [8], with an effect close to that of plant bioactive 
substances [9]. These insects’ gut microbiota comprises a diverse range of microorganisms 
that produce bioactive compounds that, among other things, protect their host from path-
ogenic assault [10]. However, little is known about these bioactive compounds, often rich 
in peptides and other classes of natural products. 
Antimicrobial peptides/polypeptides (AMPs), for example, are an innate component 
of insect immunity found in their hemolymph and have been shown to have significant 
biological activity against fungi, viruses, parasites, and, most importantly, antibiotic-re-
sistant bacteria [11,12]. Antimicrobial peptides (AMPs) are small molecules that range in 
size from 10 to 100 amino acid (AA) residues and are produced by all living organisms. 
The rich diversity of insects makes them strong candidates to screen for novel sources of 
AMPs. The black soldier fly (BSF) Hermetia illucens L. (Diptera: Stratiomyidae), in particu-
lar, has been shown to have an extraordinary ability to live in hostile environments rich 
in microbial colonies, making it one of the most promising sources of AMPs [13]. Some of 
the AMPs identified from the BSF larvae and adult transcriptomes include defensin (44%), 
cecropins and lysozymes (18%), attacins (7%), and other AMPs (<5%) [13]. Structural ex-
amples of the described defensin-like peptide (DLP4) and cecropin (CLP1) from BSF are 
shown in Figure 1. Many other AMPs found in insects have been compiled in a mini-
review by Wu et al. [14], which sheds light on their biological effects [14]. In their analysis, 
these authors delved mainly on the various modes of action suggested for insect AMPs. 
However, there is paucity of evidence to support the structure–activity relationships 
(SARs) and mechanisms that underpin AMP activity. There is also no information on 
other antimicrobial chemicals produced by insects, which is the subject of the current re-
view, with special emphasis on edible insects. 
 
Figure 1. (A) Sequence of DLP4 (40-amino acid sequence, 4267 Da), [15] and CLP1 (46_amino acid 
sequence, 4840 Da) [16]. (B) Structural representation and molecular modeling of DLP4 (pdb code: 
2nz3) and CLP1 (pdb code: 2npi). Molecular models were generated with PyMOL 2.4.1. 
Infections caused by resistant bacteria, on the other hand, are more difficult to treat, 
jeopardizing the efficacy of first-line antibiotics. As such, drugs that are more effective, 
more widely available, and have less toxic side effects are in high demand to treat these 
infections [17,18]. Thus, this review will discuss the recent advances in the identification 
and bioactivity of antimicrobial compounds derived from selected African edible insects 
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and opportunities for their use as templates for developing next-generation drugs to com-
bat multidrug-resistant pathogens. Although this review targets edible insects from Af-
rica, in some sections, references are drawn from other parts of the world to buttress the 
growing demand for antibiotics. 
2. Edible Insects in Africa and Their Microbiota 
The consumption of insects (entomophagy) is an ancient and traditional practice, 
which has been recognized as one of the ways to alleviate hunger around the world, par-
ticularly in Latin America, Africa, and Asia. In sub-Saharan Africa, edible insects have 
been used as food because they are a good source of protein and essential fatty acids [19–
21]. They are also high in micronutrients such as copper, iron, magnesium, manganese, 
phosphorus, selenium, and zinc, as well as vitamins such as riboflavin, pantothenic acid, 
biotin, folic acid, vitamin A, B complex, and C [22,23]. 
Africa has the most diverse collection of edible insects, with over 500 species includ-
ing caterpillars (Lepidoptera), termites (Isoptera), locusts, grasshoppers and crickets (Or-
thoptera), ants, wasps and bees (Hymenoptera), bugs (Heteroptera and Homoptera), dragon-
flies (Odonata), flies (Diptera), and beetles (Coleoptera) [24]. As such, these different insect 
orders may associate with a diversity of microorganisms including bacteria and fungi. 
Spore-forming bacteria and Enterobacteriaceae, for example, have previously been 
detected in crushed mealworms and crickets and were believed to be released from the 
gut [25]. Furthermore, research on cricket (Gryllotalpa Africana), weevil (Rhynchophorus 
phoenicis), and butterfly (Bematistes alcinoe) species showed that the majority of microor-
ganisms belonged to the two bacterial genera Bacillus and Staphylococcus, with sapro-
phytes accounting for the remainder [26]. 
Additionally, a recent study profiled the black soldier fly larval gut microbiota, 
which included bacterial and fungal communities from four different substrates (brewers’ 
spent grain, kitchen food waste, poultry manure, and rabbit manure). Metagenomic anal-
ysis revealed 21 bacterial and 20 fungal genera. These findings further indicated that the 
composition and abundance of the identified microbes differed depending upon the sub-
strate [27]. The highly represented bacterial population in BSF larvae reared on all sub-
strates except rabbit waste, for example, belonged to the Dysgonomonas genus. In contrast, 
the Campylobacter genus was more abundant in BSF larvae reared on rabbit waste than in 
larvae raised on the other three substrates [27]. Pichia, Cyberlindnera, and Saccharomycecodes 
were found in high concentrations in brewers’ spent grain, kitchen food waste, and rabbit 
manure, respectively, in the fungal community. These findings suggest that there is a large 
population of microorganisms that is yet to be identified, including those found in edible 
insects, from which new scaffolds of drugs with potentially new modes of action could be 
developed to target multidrug-resistant bacteria. 
3. Multi-Drug Resistance (MDR) 
The development of antibiotic resistance has continued to warrant the search for 
novel bioactive metabolites in the field of natural products. A contributing factor to the 
problem of multi-drug resistance is the widespread and uncontrolled usage of antibiotics 
to treat bacterial infections. Scientific research has shown that some disease-causing mi-
crobes have developed resistance against certain available classes of antibiotics. These in-
clude the “ESKAPE” organisms, i.e., Enterococcus faecium, Staphylococcus aureus, Klebsiella 
pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter sp. [28]. 
Methicillin-resistant Staphylococcus aureus (MRSA) is a classic example of a notorious case 
of multi-drug resistance development. It has developed resistance against the major clas-
ses of antibiotics such as aminoglycosides, macrolides, tetracycline, chloramphenicol, and 
lincosamides [29]. 
Multi-drug resistance (MDR) is therefore linked to several disease treatment chal-
lenges, including prolonged time of infection in patients due to the increased spread of 
resistant pathogens as a result of first-line drug efficacy, high treatment costs that may 
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lead to high morbidity and mortality rates, and the exposure of immune-compromised 
patients as an easy target due to decreased drug efficacy [30]. These reports encourage the 
exploration of alternative sources of antibiotics to overcome MDR. That begs the question 
of whether insects could serve as a potential source for identifying novel antibiotics. 
4. Insects as Potential Antibiotic Producers 
Insects not only perform a variety of roles in the environment, but also host a diverse 
community of microorganisms. The multifaceted cellular and humoral mechanisms com-
prise the innate immune system of an insect [31,32]. The cellular mechanism is based on 
phagocytosis being activated by enzymes and invading microorganisms being encapsu-
lated by the hemolymph. The humoral response, on the other hand, is involved in the 
production of broad-spectrum antimicrobial peptides (AMPs), reactive oxygen or nitro-
gen intermediates, and complex enzymatic cascades that help to regulate hemolymph co-
agulation or melanization [33,34]. The presence of microorganisms invading insects 
causes the fat body to rapidly synthesize AMPs, which are then secreted into the hemo-
lymph [35,36]. 
Previous research indicates that each insect species produces a distinct antimicrobial 
peptide that acts against specific microorganisms, as shown in the review by Yi et al. [11]. 
However, in order to boost the insect’s defense system against other pathogens, some of 
the peptides are expressed concurrently, encouraging synergism [36–38]. For example, 
when a cecropin (LSer-Cec6) and a defensin (LSer-Def4) from the wound maggot Lucilia 
sericata were examined together, they showed significantly increased antibacterial activity 
[39]. Furthermore, the amount of AMPs produced by insects varies greatly depending on 
the species. As such, AMPs have distinct modes of action, such as altering the electro-
chemical gradient at the membrane, producing reactive oxygen/nitrogen species 
(ROS/RNS) that cause cell death, inhibiting protein synthesis, and permeabilizing the cell 
membrane [38,40]. Antimicrobial peptides (AMPs) have pharmacological properties such 
as low molecular weight, high water solubility, broad-spectrum antimicrobial activity, 
and low levels of cytotoxicity [41]. 
5. The Chemistry of Microorganisms from Selected Edible Insects 
In this section, chemical compounds identified in microbes found in the six selected 
edible insects (black soldier fly, termites, beetles, locusts, caterpillars, and crickets) are 
highlighted. Some of these chemicals have been reported to have antibacterial, antifungal, 
antimalarial, anti-inflammatory, and cytotoxic activities. 
5.1. Black Soldier Fly Hermetia Illucens (Diptera: Stratiomyidae) 
The gut of the black soldier fly (BSF) larvae has been shown to harbor beneficial mi-
crobes and fungi that also control pathogens [42]. Thus, the microbes linked to it are a 
good target for the discovery of new antimicrobial compounds of pharmaceutical rele-
vance. In some studies, the Pichia genus was found to be related to the larvae fed on veg-
etable waste, whereas Trichosporon, Rhodotorula, and Geotrichum were the most abundant 
genera in the larvae fed on chicken feed only [42]. Regarding the production of AMPs, it 
is highly conserved between insects and may only vary between species depending on 
their respective habitats [43]. In BSF larvae, AMPs have been classified as defensins (cys-
teine-rich peptides), cecropins (α-helical peptides), attacins (glycine-rich peptides/pro-
teins), and diptericins (a family of related glycine-rich antibacterial peptides), as well as 
lipids (hexanedioic acid) [43,44]. In a previous analysis, scores that predicted the biologi-
cal activity of unknown peptides in the transcriptomes of BSF larvae and adults were de-
termined using different algorithm in in silico tests. Biological activities that were pre-
dicted included antimicrobial, anticancer, antiviral, and antifungal properties [13]. Fol-
low-up in vitro studies are yet to be carried out to validate these findings. 
Antibiotics 2021, 10, 621 5 of 25 
 
The general mechanisms of action of AMPs have been investigated in a few studies 
[45,46]. For example, Park et al. [47], demonstrated that H. illucens larvae extracts have 
antibacterial properties against Gram-positive S. aureus, methicillin-resistant S. aureus 
(MRSA), and Gram-negative Pseudomonas aeruginosa [47]. The methanol extract of BSF was 
found to inhibit the growth of K. pneumoniae, Neisseria gonorrhoeae, and Shigella sonnei bac-
teria, whereas the extract elicited no antibacterial effects against the bacteria B. subtilis, 
Streptococcus mutans, and Sarcina lutea [48]. 
The expression and characterization of stomoxynZH1 (encoded by a 189-basepair 
gene) with antimicrobial activity against Escherichia coli and S. aureus is one of two recent 
promising results involving AMPs from H. illucens [49]. In addition, DLP4, a novel AMP 
isolated and characterized from H. illucens hemolymph larvae, showed potent activity 
against MRSA and methicillin-susceptible S. aureus (MSSA) [15]. 
Furthermore, secondary metabolites from Chrysosporium multifidum broth extract, a 
fungus isolated from the midgut of BSF larvae fed on fresh unsterilized chicken guano, 
have been described in the literature. As shown below, these molecules include six pyrone 
derivatives (1–6) and one diketopiperazine (7) (Figure 2). The epoxy moiety containing α-
pyrone (5) was found to have moderate antibacterial activity against 43,300 ATCC strains 
of methicillin-resistant Staphylococcus aureus (MRSA) [10]. Thus, AMPs and small mole-
cules from H. illucens are still understudied, despite the fact that they have strong antibac-
terial properties. So far, only one fungal strain has been targeted within the rich microbiota 
of H. illucens, with no reports on the antifungal and cytotoxic effects of the identified mol-
ecules. 
 
Figure 2. Small molecules isolated from the midgut of BSF larvae. 
5.2. Termites (Isoptera) 
Termites are recognized as beneficial insects in agriculture, entomotherapy, and the 
environment. Their ability to act as mediators of the process of decomposing plant organic 
matter and as influential agents in soil formation, particularly in tropical forests, is one of 
their important ecological roles [50]. The diversity of termite gut communities is astound-
ing, but the function of each group of symbionts is poorly understood. Hemicellulose-
degrading bacteria, lignolytic bacteria, cellulolytic bacteria, aromatic compound-degrad-
ing bacteria, and nitrogen-fixing bacteria are among the primary termite intestinal micro-
organisms [51–59]. According to research, the most abundant bacteria found in both 
higher and lower termites are strict aerobes or facultative anaerobes. There is also evi-
dence that the most abundant bacteria in termite guts belong to the Staphylococcus and 
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Bacillus genera [60,61]. Moreover, research has previously discovered a link between the 
major gut bacteria and the termite family (see Table 1) [62]. 
Table 1. Classification of microorganisms found in termites. 
Termite Family/Genera Related Microbe Genera Source Ref 
Formosan termite: Coptotermes 
formosanus 
Serratia marcescens, Enterobacter aerogens, Enterobacter 
cloacae, and Citrobacter farmeri. 
Hindgut [63] 
Odontotermes formosanus 
Bacillus sp., Citrobacter freundii, Pseudomonas aeruginosa 
Salmonella entrica, Enterococcus casseliflavus, Staphylococcus 
gallinarum, and Serratia marcescens. 
Gut [52] 
Mastotermes darwiniensis Streptococcus sp. Gut [62] 
Cryptotermes primus Streptococcus sp. Gut [62] 
Rhinotermitidae species: (Heterotermes 
ferox, Coptotermes acinaciformis, C. 
lacteus, and Schedorhinotermes 
intermedius intermedius) 
Enterobacter sp. Gut [62] 
Termitidae species (Nasutitermes 
exitiosus, N. graveolus, N. walkeri) Staphylococcus sp. Gut [62] 
Additional studies have shown that Streptomyces strains isolated from termites had 
significantly higher inhibition activity against Gram-negative bacteria than soil isolates 
[64]. Chemical analysis of termite-associating microbes, in particular fungi from O. for-
mosanus, revealed three small molecules named 5-hydroxyramulosin (8), biatriosporin M 
(9) from the Pleosporales sp. BYCDW4, and 1-(2,5-dihydroxyphenyl)-3-hydroxybutan-1-
one (10) from the Microdiplodia sp. BYCDW8. Investigation of their biological activity in-
dicated that compound (10) had moderate inhibitory activity against B. subtilis and S. au-
reus [65]. Streptomyces davaonensis YH01, isolated from the body surface of the queen of 
the termite O. formosanus, demonstrated antibacterial activity. Roseoflavin (11) and 8-me-
thylamino-8-demethyl-D-riboflavin (12), which exhibited antibacterial activities, were dis-
covered in a subsequent study on the same strain [66]. Their absolute stereochemistry, 
however, is yet to be assigned (Figure 3). 
Several other studies have shown that Actinobacteria in association with Macrotermes 
natalensis (a fungus-growing termite species) led to the isolation of natalamycin (13) from 
Streptomyces sp. M56, a new antifungal geldanamycin derivative [67]. Termisoflavones A–
C (14–16) and eight isoflavonoid molecules (17–24) have been reported from Streptomyces 
sp. RB1 [68]. In addition, the structures of the complex nonribosomal peptide synthetase–
polyketide synthase (NRPS/PKS) hybrid depsipeptides dentigerumycins B–D (25–27) 
were characterized from Streptomyces sp. M41 [69]; actinomycin D (28) was isolated from 
Streptomyces sp. RB94 [70]. The glycosylated polyketide macrolactams macrotermycin A–
D (29–32) have also been described in Amycolatopsis sp. M39 [71], and a group of tropolone 
derivatives, rubterolone A–F (33–38,) were found in Actinomadura sp. RB29/5-2 [70,72]. Co-
culture studies of Streptomyces sp. RB108 with Pleosporales sp. also yielded the PKS-derived 
barceloneic acid A (39), which acts as a farnesyl-protein transferase inhibitor (Figures 4 
and 5) [70,73]. Other than (19) and (24), no antimicrobial activity was found for termiso-
flavones and isoflavanoid compounds (see Table 2). At a cisplatin dose of 25 μM, the two 
compounds reduced cisplatin-induced kidney cell damage to 80% of the control value 
[68]. 
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Table 2. Small molecules from selected edible insects. 
Insect 
Origin, Producer Organ-
ism Compounds Biological Activity  Ref. 
Black Soldier Fly Chrysosporium multifidum 
Pyrone derivatives (1–6), 
Diketopiperazine (7) Antibacterial [10] 
Termites Pleosporales sp. BYCDW4 
5-Hydroxyramulosin (8), 


















 Streptomyces sp. M56 
Natalamycin (13), 
Efomycins K (40), and L 
(41), 
Efomycin M (42), 
















 Streptomyces sp. M41 
Dentigerumycins B–D 
(25–27) - [69] 
 Streptomyces sp. RB94 Actinomycin D (28)  Actibacterial, antitumor [70,81,82] 












sp. RB108 with Pleospora-
les sp. 
Barceloneic acid A (39)  Farnesyl-protein transfer-
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 Streptomyces sp. MspM5 
Microtermolide A–B (47–
48)  - [84] 
 Pseudoxylaria sp. X802 Pseudoxyallemycin B (49) Antibacterial [85] 













 Actinomadura sp. RB29 Rubrominin A–B (55–56) - [70] 
Beetles 
Pine beetles, Streptomyces 
sp. 
Mycangimycin (57), 
Frontalamide A (58), and 






Helvolic acid (61)  Antifungal [89] 
 
Rove beetle, Pseudomonas 
sp. [49–52] 
Pederin (62) Anticancer [90] 
 Dung beetle Tripartilactam (63) Na+/K+ ATPase inhibitor 
[91–95] 
 Actinobacteria   
  Coprismycin A–B (64–65) Neuroprotective effects 
  Collismycin A (66)  
  SF2738D (67)  
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  Tripartin (68) 
Histone H3 lysine 9 
demethylase KDM4 
inhibitor 





  Coprisidin A (71) Na+/K+ ATPase inhibitor 
  Coprisidin B (72) NAD(P)H:quinone 
oxidoreductase 1 inducer 
 
Dung beetle, Brevibacillus 
sp. PTH23 
Lenzimycins A–B (73–74) Antibacterial [96] 
 Catharsius molossus 
Molossusamides A–C 




















Glidobactin A (87) - 
[99] 
Luminmycin A (88) - 
Luminmycin D (89) Cytotoxic, Proteasome 
inhibitor 
 
Antibiotics 2021, 10, 621 9 of 25 
 
 
Figure 3. Small molecules isolated from fungi related to Odontotermes formosanus and Streptomyces strains. 
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Figure 4. Peptides from Streptomyces strains and macrolactams from Amycolatopsis sp. associated with Macrotermes na-
talensis termites. 
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Figure 5. Tropolone derivatives, small molecules obtained after co-culture experiments, and efomycin-related compounds. 
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Further research on Streptomyces sp. M56 resulted in the identification of two new 
compounds with an unsaturated enone moiety, named efomycins K (40) and L (41), in 
addition to the well-known efomycin M (42), a potent and specific inhibitor of selectin 
[74–76]. Subsequently, five known and structurally related hemiketal derivatives—efo-
mycin G (43) [77], elaiophylin (44) [78], 11-O-methylelaiophylin (45) [78], and 11,11′-O-
dimethylelaiophylin (46)—were isolated [79,80]. 
The investigation of Streptomyces sp. MspM5 found in a South African fungus-grow-
ing termite, Microtermes species, led to the discovery of two novel PKS/NRPS pathway 
peptides. The peptides, known as microtermolide A (47) and B (48), exhibited no antibac-
terial or antifungal activity [84]. Pseudoxylaria sp. X802, which evolved from Microtermes 
sp., produces a number of antimicrobial compounds. Pseudoxyallemycin B (49) is one of 
the isolated antibacterial peptides, with a rare and chemically accessible allene moiety 
(Figure 6) [85]. 
Three new cyclic tripeptides named natalenamides A–C (50–52) were isolated from 
the termite-associated Actinomadura sp. RB99 isolated from the fungus-growing termite 
Macrotermes natalensis. Compounds 50 and 51 exhibited weak cytotoxicity in HepG2 and 
HeLa/A549 cells, whereas compound 52 inhibited IBMX-mediated melanin synthesis in a 
dose-dependent manner [86]. Furthermore, co-cultivation experiments with Actinomadura 
sp. RB29 and Trichoderma sp. led to the discovery of antifungal compounds such as 
banegasine (53) and cyclo(NMe-L-3,5-dichlorotyrosine-Dhb) (54) [70]. 
 
Figure 6. Peptides isolated from the microbiota of Microtermes sp. and Macrotermes natalensis termites. 
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In silico analysis of the genome of Actinomadura sp. RB29 from Macrotermes natalensis, 
using antiSMASH and tandem MS2 data submitted to Global Natural Product Social Mo-
lecular Networking (GNPS), and subsequent RiPPquest processing revealed the presence 
of two lanthipeptides with proposed structures of rubrominin A (55) and B (56) [70]. Their 
gene cluster resembles that of cinnamycin (Figure 7) [100–102]. Except for the Actinobac-
teria microorganisms, the termite family has a large range of microbiota that has not been 
thoroughly investigated in terms of their chemical capacity as presented here. The bulk of 
their chemical structures consists of peptides and isoflavonoids, which makes them pecu-
liar. 
 
Figure 7. Proposed lanthipeptides from Actinomadura sp. RB29 linked to Macrotermes natalensis termites. Abu, 2-aminobu-
tyric acid. 
5.3. Beetles (Coleoptera) 
Beetles are generally known to benefit the environment (nutrient recyclers, pollina-
tors), but a significant portion of them are pests of economically important crops and stor-
age products [103]. Bark beetles, in particular the southern pine beetle (Dendroctonus 
frontalis), are damaging to trees [104]. They have a symbiotic relationship with the fungus 
Entomocorticium sp. A, which serves as food for the beetle larvae [105]. 
Recent research has revealed a link between various beetle species and four bacterial 
phyla, Proteobacteria, Firmicutes, Actinobacteria, and Bacteroidetes, as well as three fungal 
phyla, Ascomycota, Zygomycota, and Basidiomycota. These microbial communities were dis-
covered to differ depending on the beetle host, individual organism, and environment 
[106]. 
Actinobacteria, particularly Streptomyces, have been described as having a chemical 
defense mechanism that produces antimicrobial compounds that aid in the fight against 
infectious disease. Mycangimycin (57), frontalamide A (58), and frontalamide B (59), for 
example, were isolated from a Streptomyces strain that was symbiotically associated with 
the southern pine beetle (Dendroctonus frontalis). Mycangimycin inhibits the beetles’ an-
tagonistic fungus Ophiostoma minus and has potent antimalarial activity. Frontalamide A 
and frontalamide B have antifungal properties [87,88]. 
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Nakashima et al. studied the fungal strain Fusarium sp. from the ambrosia beetle Eu-
walecea validus in the early 1980s. Its culture extract contained two antifungal compounds, 
cerulenin (60) and the nortriterpenoid helvolic acid (61), which inhibited the growth of 
mold fungi and are thought to suppress bacterial contaminations [89]. Chemical analysis 
of rove beetles (Paederus sp.) yielded a complex polyketide pederin (62) molecule from an 
endosymbiotic Pseudomonas sp. [49–52] that showed toxicity against predators such as 
wolf spiders in a study by Kellner and Dettner [90]. 
The soil-dwelling Korean dung beetle (Copris tripartitus) has previously been chemi-
cally studied and found to contain a diverse array of Actinobacteria. Their distinct metab-
olomic profiles resulted in the isolation of tripartilactam (63), a new tricyclic macrolactam 
that lacks antimicrobial activity but acts as a Na+/K+ ATPase inhibitor [91,92]. Follow-up 
studies by the same group revealed phenylpyridines, coprismycin A–B (64–65) exhibiting 
neuroprotective effects, dipyridines, collismycin A (66), SF2738D (67), and a dichlorinated 
indanone tripartin (68), an inhibitor of the histone H3 lysine 9 demethylase KDM4 in HeLa 
cells [91,93]. More recently, new cyclic heptapeptides named coprisamides A–B (69–70) 
were isolated from a Streptomyces strain found in the gut of C. tripartitus, demonstrating 
significant activity for the induction of quinone reductase (Figure 8) [94]. About a year 
later, the naphthoquinone–oxindole alkaloids Coprisidins A (71) and B (72) were isolated 
from the same Streptomyces strain previously studied by Um et al. [95]. Coprisidin A (71) 
was shown to inhibit the action of Na+/K+ ATPase, whereas Coprisidin B (72) showed in-
duction of NAD(P)H:quinone oxidoreductase 1 (Figure 9) [95]. 
The antibacterial molecules lenzimycins A (73) and B (74) were isolated from the 
Brevibacillus sp. PTH23, associating with the dung beetle Onthophagus lenzii. These mole-
cules were also discovered to be effective in activating a reporter system designed to de-
tect bacterial cell envelope stress [96]. Furthermore, the study of biological agents from 
the entire body of the dung beetle Catharsius molossus resulted in the discovery of three 
new N-acetyldopamine dimers, molossusamide A–C (75–77), in addition to other known 
compounds, i.e., cis-2-(3′,4′-dihydroxyphenyl)-3-acetylamino-7-(N-acetyl-2″-amino-eth-
ylene)-1,4-benzodioxane (78) and trans-2-(3′,4′-dihydroxyphenyl)-3-acetyl-amino-7-(N-ac-
etyl-2″-aminoethyl)-1,4-benzodioxane (79) [97]. With the exception of 78, which exhibited 
inhibitory effects against COX-1 and COX-2, these molecules lacked biological activity 
against the tested organisms (see Table 2 and Figure 9). 
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Figure 9. Chemical structures of compounds isolated from microorganisms linked to the dung beetles. 
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5.4. Locusts (Orthoptera: Acrididae) 
Locusts, like other insects, have bacterial cells both inside and outside their bodies, 
such as on their cuticles. With respect to other locust species, the bacterial composition of 
the desert locust (Schistocerca gregaria) gut has been extensively described [107]. For exam-
ple, the bacteria in the hindgut of the desert locust were discovered to be relatively simple, 
consisting of members of the families Enterobacteriaceae (including Enterobacter and 
Klebsiella) and Enterocococeaea [108]. This study followed previous research that found gut 
bacterial flora in S. gregaria that included Escherichia coli, Enterobacter liquefaciens, Klebsiella, 
Pneumoniae, and Enterobacter cloacae [109,110]. The lack of complexity in the desert locust’s 
gut microbiota could be attributed to its simple structure and short throughput time. 
Despite numerous studies on the desert locust, there is little documented knowledge 
about the antimicrobial compounds it produces. Using gas chromatography–mass spec-
trometry (GC–MS), researchers recently investigated how ingested phytosterols are me-
tabolized and biotransformed into other derivatives such as desmosterol, (3β, 5α) cho-
lesta-8, 14, 24-trien-3-ol, 4, 4-dimethyl, (3β, 20R) cholesta-5, 24-dien-3, 20-diol, present as 
the dealkylated products of lanosterol in the gut [111]. However, the biological activity of 
these sterols against multidrug-resistant pathogens is yet to be investigated. 
5.5. Caterpillars (Lepidoptera) 
Caterpillars are among the most popular, consumed, and economically valuable ed-
ible insects in the tropics, because they have high protein and fat content [21]. They are 
mostly found in tropical rainforests. There are over 130 edible caterpillar species con-
sumed in Africa alone, compared to nearly 400 species worldwide [112]. Despite their 
enormous contribution to global food security, little is known about their ecological rele-
vance [113], associated microbiota, and antimicrobial potential. Caterpillars, unlike other 
living organisms, do not have a gut microbiota, demonstrating their freedom from sym-
bionts [114]. 
So far, volicitin (80), N-(17-hydroxy-linoleoyl)-L-glutamine (81), N-linolenoyl-L-glu-
tamine (82), N-linoleoyl- L-glutamine (83) and volicitin-related compounds (84), linolenic 
acid (85), and the 17-hydroxylinolenic acid (86) (Figure 10) have been discovered in the 
oral secretions of three Noctuidae species, i.e., Helicoverpa armigera, Mythimna separata, and 
Spodoptera litura, as well as one Sphingidae species, Agrius convolvuli [98]. The structure–
activity relationships of volicitin-related compounds were investigated to determine the 
elicitor activity of volatiles from corn seedlings, revealing that chirality at C-17 in the lin-
olenic acid chain had no effect on bioactivity. However, it was discovered that the L-glu-
tamine moiety was more important than the hydroxyl moiety [115]. Derivatizing these 
molecules can lead to a wide variety of agricultural applications, such as identifying vol-
atile components that can be used in pest control. Interestingly, there is no evidence of 
these compounds being associated with the gut microbiota of caterpillars. 
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5.6. Crickets (Orthoptera) 
Crickets have traditionally been used as a source of medicine for a variety of ailments. 
In Korea, for example, the mole cricket Gryllotalpa Africana (Gryllotalpidae) is used to treat 
urine retention, urolithiasis, edema, lymphangitis, and furuncles [116]. In Latin America, 
the house cricket Acheta domesticus (Gryllidae) is used to treat scabies, asthma, eczema, li-
thiasis, earache, oliguresis, rheumatism, urine retention, urinary incontinence, and oph-
thalmological problems [117]. The crickets Paragryllus temulentus (Gryllidae) and Gryllus 
assimilis (Gryllidae) are both useful in the treatment of rheumatism and warts. Interest-
ingly, bacteria from the Citrobacter, Klebsiella, Yersinia, Bacteroides, and Fusobacterium gen-
era were found in the gastrointestinal tract of the house cricket Acheta domestica [118]. The 
Photorhabdus asymbiotica bacterium is known to have a two-part life cycle that colonizes 
the intestines of entomophagous nematodes and necessitates adaptation to both symbiotic 
and pathogenic phases [119]. The infection of live crickets with the Photorhabdus asymbi-
otica bacterium resulted in the isolation and characterization of glidobactin A (87), lu-
minmycin A (88), and luminmycin D (89). Only compound (89) was found to be cytotoxic 
to human pancreatic cells and inhibited proteasome activity (Figure 11) [99]. The macro-
lactam center of these molecules consists of nonribosomal peptide synthetase modules 
catalyzing the condensation of 4-hydroxylysine, L-alanine, and malonyl-CoA [120]. Addi-
tionally, there is a threonine moiety connecting it to the fatty acid side chain. In this regard, 
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from the perspective of structure–activity relationships, the hydroxyl group on the threo-
nine side chain and the R1 positions can be targeted as accessible sites for modifying the 
molecule to potentially enhance its biological activities. 
 
Figure 11. Compounds obtained from crickets infected with the Photorhabdus asymbiotica bacterium. 
6. Future Perspectives 
Insects thrive in Africa’s tropical climate. However, this review reveals that very little 
research has been done on the chemistry of edible insects and their microbiota in Africa. 
With the current knowledge, it is imperative to advance studies to a higher level, by de-
veloping various methods to isolate and characterize new AMPs and small molecules. 
This may involve varying the habitats in which the insects are reared to stimulate different 
microbiota, which may increase the likelihood of discovering new pharmacologically rel-
evant metabolites. It is also possible to screen different life stages because insects may live 
in different habitats, aquatic and/or terrestrial; hence, their potential association with dif-
ferent microorganisms. Moreover, derivatization can be facilitated by using known chem-
ical structures as a template. Aside from that, the identified molecules can be tested in 
binary or ternary mixtures to increase their synergistic/additive effectiveness against mul-
tidrug-resistant species. Bioengineering and biotransformation of species and scaffolds, 
respectively, may also enhance the observed biological activity. In addition, insights into 
how these molecules are synthesized by various organisms would be useful to identify 
the enzymes involved. These studies should therefore help to clarify what function these 
microorganisms play in their hosts and pave the way for the production of antimicrobial 
agents. 
7. Concluding Remarks 
This review has shown that edible insects are a good source of novel antimicrobial 
peptides and compounds that can be screened against multidrug-resistant pathogens. 
StomoxynZH1 and DLP4 are among the AMPs found in the BSF with potent antibacterial 
activity. The majority of isolated microorganisms from which small molecules have been 
identified were sourced from the insect’s gut. Overall, termite-related microorganisms are 
the most researched in terms of chemical diversity. In comparison to fungal strains, bac-
terial strains, especially Actinobacteria, have been extensively studied. As it is evident, 
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Streptomyces yielded 25 (52%) of the 48 molecules isolated from termites, while 13 (27%) 
were isolated from Actinomadura species. In terms of the chemistry of BSF-associated mi-
croorganisms, only one fungal strain has been investigated so far and identified to contain 
primarily antibacterial α-pyrone molecules. In addition, about 29% of the small molecules 
characterized herein were obtained from the gut microbiota of beetles. Apart from sterols 
that have been identified in locusts, there is little knowledge on antimicrobial compounds 
that they may produce. Caterpillars, on the other hand, contain mainly linolenic acid-de-
rived molecules in their oral secretions. Although the number of studies documenting an-
timicrobial peptides and small molecules is on the rise, the microbiota of edible insects 
still remains an understudied topic. 
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